Physician profile
Aaron Robert Bolduc
NPI 1952697906
$8,503.92
in general payments reported to CMS, 2019-2025
16 companies · $1,020 in 2025
The $1,020 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2020: $25.90 · 2021: $117 · 2022: $437 · 2023: $5,711 · 2024: $751 · 2025: $1,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,964 · Education: $2,500 · Food and Beverage: $2,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,964.43 |
| Education | $2,500.00 |
| Food and Beverage | $2,017.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,699.81 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Stryker Corporation | $1,393.95 | 2023 | Chromophare F300, 1688 |
| Steris Corporation | $1,015.47 | 2023 | |
| Medtronic, INC. | $430.27 | 2022-2025 | Signia, Transorb |
| Novo Nordisk INC | $245.03 | 2023-2025 | Wegovy |
| Kerecis Limited | $143.79 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $125.00 | 2024 | Acticoat 4" X 4", Pico |
| Abbvie INC. | $109.48 | 2025 | |
| Lucid Diagnostics INC. | $98.18 | 2022 | |
| Covidien LP | $97.16 | 2019-2020 | |
| Boston Scientific Corporation | $52.55 | 2024 | |
| Arthrex, INC. | $24.00 | 2024 | |
| Lilly USA, LLC | $19.95 | 2025 | Zepbound |
| Integra Lifesciences Corporation | $18.51 | 2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Teleflex LLC | $17.64 | 2023 | Titan Sgs Standard Gastric Stapler |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $13.13 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Bolduc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.